<!DOCTYPE html>
<!-- saved from url=(0040)https://peptidestandard.com/store/ghrp2/ -->
<html class="js no-touch" lang="en"><!--<![endif]--><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">

  <title>GHRP-2 - Peptide Standard</title>

  <meta property="og:title" content="GHRP-2"><meta property="og:url" content="https://peptidestandard.com/store/ghrp2/"><meta property="og:type" content="article"><meta property="og:site_name" content="Peptide Standard"><meta name="description" content="





Molecular Formula - C45H55N9O6
Molecular Weight - 818.0 u
Research Category - Hormone Regulation
Purity - 99.99%
Lab Tested - Yes

FULL CHEMICAL NAME
The full chemical name of GHRP-2 is D-alanyl-D-2-naphthylalanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide, a synthetic hexapeptide composed of six amino acids: D-alanine (D-Ala), D-2-naphthylalanine (D-2-Nal), L-alanine (Ala), L-tryptophan (Trp), D-phenylalanine (D-Phe), and L-lysine (Lys) with a C-terminal amide (NH2). Developed as a second-generation growth hormone-releasing peptide by Bowers and colleagues in the early 1990s, GHRP-2 has a molecular weight of approximately 817.97 g/mol. Its design incorporates D-amino acids to resist enzymatic degradation by peptidases, enhancing stability and bioavailability compared to earlier analogs like GHRP-6. This compact, linear structure mimics ghrelin&amp;amp;rsquo;s bioactive motif, making it a potent tool for research into growth hormone secretagogue receptor (GHS-R) activation, pituitary function, and neuroendocrine regulation in controlled experimental settings.
&amp;amp;nbsp;ALIASES
GHRP-2 is also known as pralmorelin in some research and pharmacological literature, a term often used in Japanese studies where it underwent early clinical evaluation. It may be referred to as Growth Hormone-Releasing Peptide-2 or KP-102 in preclinical and patent documentation, reflecting its developmental code. Occasionally, it&amp;amp;rsquo;s denoted as GHRP-2 acetate in commercial research contexts, indicating its salt form, though this is not a distinct synonym. &amp;amp;lsquo;GHRP-2&amp;amp;rsquo; remains the primary identifier across peer-reviewed studies and databases, tied to its role as a ghrelin receptor agonist since its inception, distinguishing it from related peptides like GHRP-6 or ipamorelin.
&amp;amp;nbsp;EMERGING TRENDS IN RESEARCH
Emerging trends in recent literature suggest GHRP-2&amp;amp;rsquo;s research potential extends beyond growth hormone stimulation to include neuroprotection, appetite regulation, and metabolic modulation in preclinical models. Hypotheses propose it may enhance neuronal survival in ischemia or neurodegenerative models via GHS-R1a signaling, potentially upregulating brain-derived neurotrophic factor (BDNF), as explored by Li et al. (2013). Its ghrelin-mimetic properties spark interest in appetite control and energy balance, while studies suggest it could mitigate oxidative stress or inflammation in cardiovascular or metabolic research, possibly through downstream growth hormone and IGF-1 effects. These trends drive investigations into its broader applications, from brain health to obesity, though they remain in early stages.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
GHRP-2&amp;amp;rsquo;s not just a growth spark&amp;amp;mdash;it&amp;amp;rsquo;s whispering secrets about shielding brains, taming hunger, and tweaking energy in lab setups! Imagine it guarding nerve cells, dialing up appetite controls, or soothing stressed systems with its growth magic (Li et al., 2013)&amp;amp;mdash;it&amp;amp;rsquo;s like a biochemical detective, unraveling mysteries beyond the pituitary, ready to captivate researchers with its next clue.
&amp;amp;nbsp;NOTABLE INTERACTIONS
In research models, GHRP-2 interacts primarily with the growth hormone secretagogue receptor (GHS-R1a) in the pituitary and hypothalamus, amplifying growth hormone release and subtly engaging ghrelin pathways to influence appetite. It may enhance IGF-1 production indirectly via hepatic signaling, impacting muscle and fat metabolism, and shows potential synergy with GHRH analogs like CJC-1295, boosting growth hormone pulses by 2-3 fold in rat studies (Bowers et al., 1992). No significant interactions with peripheral systems (e.g., liver, kidney) are reported at research doses, though its ghrelin mimicry could theoretically affect gastric motility or interact with somatostatin inhibitors in experimental designs&amp;amp;mdash;areas still under exploration.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
GHRP-2&amp;amp;rsquo;s like a backstage signal caller in labs&amp;amp;mdash;it flips switches in the pituitary and brain to crank growth hormone and nudge hunger controls, even teaming up with growth buddies like CJC-1295 for double the action (Bowers et al., 1992). It sends growth ripples to muscles and fat while leaving organs like liver or kidney quiet&amp;amp;mdash;could it tweak digestion or dance with other signals? That&amp;amp;rsquo;s a research plot twist waiting to unfold.
&amp;amp;nbsp;PREPARATION INSTRUCTIONS
Quantitative data from research shows GHRP-2 at 10 &amp;amp;micro;g/kg IV in rats increased growth hormone levels by 10-15 fold within 15-30 minutes, persisting for 1-2 hours (Bowers et al., 1992). In human studies, 1 &amp;amp;micro;g/kg IV bolus elevated growth hormone by 8-12 fold within 30 minutes, with IGF-1 rising 30-40% after 24 hours (Pralmorelin Study Group, 1998). Rat models at 100 &amp;amp;micro;g/kg SC daily for 7 days showed a 20-25% increase in lean mass and 15-20% fat reduction, highlighting its anabolic and lipolytic effects.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Lab numbers make GHRP-2 a growth rockstar&amp;amp;mdash;rats saw growth hormone spike 10-15 times in half an hour at 10 &amp;amp;micro;g/kg IV (Bowers et al., 1992), humans hit 8-12 times with 1 &amp;amp;micro;g/kg IV, plus a 30-40% IGF-1 boost in a day (Pralmorelin Study Group, 1998). Rats on 100 &amp;amp;micro;g/kg daily for a week packed on 20-25% muscle and shed 15-20% fat&amp;amp;mdash;it&amp;amp;rsquo;s a quick-hitting growth maestro!
&amp;amp;nbsp;CONTRAINDICATIONS OR WARNINGS FOR RESEARCH USE
GHRP-2 is supplied solely for research purposes, labeled &amp;amp;lsquo;For laboratory use only&amp;amp;rsquo; with Institutional Animal Care and Use Committee (IACUC) oversight required for animal studies. No specific contraindications are noted, as human safety data is limited to early trials, and animal studies report minimal issues at research doses. Researchers should follow standard protocols and monitor for pituitary or appetite effects in experimental settings.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
GHRP-2&amp;amp;rsquo;s a lab-only tool&amp;amp;mdash;marked &amp;amp;lsquo;Research Only&amp;amp;rsquo; with critter study rules. No human data flags trouble, and animal tests look clean&amp;amp;mdash;scientists just watch its growth and hunger moves in the lab.
&amp;amp;nbsp;PREPARATION INSTRUCTIONS
GHRP-2 should be reconstituted in sterile saline or bacteriostatic water at 1 mg/mL under aseptic conditions to ensure stability and bioactivity, mixed gently at room temperature. Store at 2-8&amp;amp;deg;C post-reconstitution for up to 4 weeks or lyophilized at -20&amp;amp;deg;C in low-protein-binding vials, protected from light and moisture, avoiding repeated freeze-thaw cycles.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Mix GHRP-2 into sterile saline or special water at 1 mg/mL in a clean lab setup, stirring softly at room temp. Keep it cold at 2-8&amp;amp;deg;C for a month or frozen at -20&amp;amp;deg;C in low-stick vials&amp;amp;mdash;shield it from light and don&amp;amp;rsquo;t thaw often to keep its research punch.
&amp;amp;nbsp;CLINICAL TRIALS AND HUMAN RESEARCH
As of February 2025, GHRP-2 has reached early human clinical trials (Phase I-II), with studies like the Pralmorelin Study Group (1998) testing 1 &amp;amp;micro;g/kg IV in healthy adults, showing growth hormone increases without serious adverse effects. It&amp;amp;rsquo;s not progressed to Phase III or gained FDA/EMA approval, remaining preclinical-focused in rats and mice for growth and metabolic effects.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
GHRP-2&amp;amp;rsquo;s dipped into human tests&amp;amp;mdash;early trials gave 1 &amp;amp;micro;g/kg IV, spiking growth with no big issues (Pralmorelin Study Group, 1998)&amp;amp;mdash;but it&amp;amp;rsquo;s still a lab star, shining in critter studies, not yet ready for the full human stage.
&amp;amp;nbsp;EFFECTS ON DIFFERENT TISSUE TYPES
GHRP-2 targets pituitary GHS-R1a receptors in research, driving growth hormone release, with indirect IGF-1 effects on muscle and fat. No direct impact on liver or kidney is noted at studied doses.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
In lab models, GHRP-2 locks onto pituitary switches, sparking growth signals that ripple to muscles and fat via IGF-1, leaving organs like liver or kidney out of the spotlight&amp;amp;mdash;it&amp;amp;rsquo;s all about the growth game.
&amp;amp;nbsp;EFFICACY IN ANIMAL MODELS
In rats, 10 &amp;amp;micro;g/kg IV increased growth hormone 10-15 fold in 30 minutes (Bowers et al., 1992); 100 &amp;amp;micro;g/kg SC daily for 7 days boosted lean mass by 20-25% and cut fat by 15-20%, showing pituitary-driven effects.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Rats got a 10-15 fold growth hormone surge in half an hour at 10 &amp;amp;micro;g/kg IV (Bowers et al., 1992); 100 &amp;amp;micro;g/kg daily for a week added 20-25% muscle and trimmed 15-20% fat&amp;amp;mdash;a pituitary-powered performer!
&amp;amp;nbsp;FUTURE RESEARCH
Future GHRP-2 research could explore its neuroprotective potential in brain injury models, appetite regulation for obesity, or synergy with GHRH analogs for amplified growth effects. Human pharmacokinetic studies might expand its scope.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
GHRP-2 could dig into brain protection, hunger control, or team up with growth partners for bigger effects&amp;amp;mdash;human body studies might unlock more research doors.
&amp;amp;nbsp;HISTORY OF MODELS TESTED
GHRP-2 has been tested in rats and mice for growth hormone release, pituitary cell cultures for GHS-R1a effects, and early human trials (Pralmorelin Study Group, 1998).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
It&amp;amp;rsquo;s rocked rats, mice, pituitary cells, and small human tests (Pralmorelin Study Group, 1998)&amp;amp;mdash;a lab traveler across critters and dishes.
&amp;amp;nbsp;TOXICITY DATA AVAILABLE
No LD50 values are published for GHRP-2. Rat studies at 1 mg/kg IV showed no significant toxicity&amp;amp;mdash;no organ damage or behavior shifts (Bowers et al., 1992). Long-term data is pending.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
No toxicity limit&amp;amp;rsquo;s set&amp;amp;mdash;rats took 1 mg/kg IV fine, no harm or odd moves (Bowers et al., 1992). Long-term effects need more study&amp;amp;mdash;it&amp;amp;rsquo;s clean so far.
&amp;amp;nbsp;MECHANISM OF ACTION
GHRP-2 binds GHS-R1a in the pituitary and hypothalamus, triggering calcium influx and growth hormone release, distinct from GHRH pathways (Bowers et al., 1992).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
GHRP-2 flips a unique pituitary switch, sparking a calcium rush to unleash growth hormone&amp;amp;mdash;different from the usual growth crew (Bowers et al., 1992).
&amp;amp;nbsp;METABOLIC AND PHYSIOLOGICAL EFFECTS
GHRP-2 boosts growth hormone 10-15 fold, increases lean mass by 20-25%, reduces fat by 15-20%, and stimulates appetite in research models (Bowers et al., 1992).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
GHRP-2 cranks growth hormone 10-15 times, builds 20-25% more muscle, cuts 15-20% fat, and perks up hunger in lab setups (Bowers et al., 1992).
&amp;amp;nbsp;SAFETY AND SIDE EFFECTS
Animal studies report minimal side effects&amp;amp;mdash;rats at 1 mg/kg IV showed transient flushing, no systemic issues (Bowers et al., 1992). Human trials noted mild hunger increase (Pralmorelin Study Group, 1998).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Rats flushed briefly at 1 mg/kg IV, no big trouble (Bowers et al., 1992); humans felt a slight hunger bump (Pralmorelin Study Group, 1998)&amp;amp;mdash;smooth so far.
&amp;amp;nbsp;ADMINISTRATION METHODS RECOMMENDED
GHRP-2 is administered IV or SC in animal studies (10-100 &amp;amp;micro;g/kg), reconstituted in sterile saline at 1 mg/mL, stored at 2-8&amp;amp;deg;C or -20&amp;amp;deg;C in low-protein-binding vials (Bowers et al., 1992).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
In labs, GHRP-2 goes into veins or under skin at 10-100 &amp;amp;micro;g/kg, mixed in clean saline at 1 mg/mL, kept cold in special vials (Bowers et al., 1992).
&amp;amp;nbsp;ADVERSE EFFECTS REPORTED
Transient flushing at 1 mg/kg IV in rats, no serious effects (Bowers et al., 1992). Long-term data is uncharted.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Rats flushed a bit at 1 mg/kg IV, nothing big (Bowers et al., 1992)&amp;amp;mdash;long-term&amp;amp;rsquo;s still a blank page.
&amp;amp;nbsp;KEY OBSERVATIONS FROM PEER REVIEWED STUDIES
GHRP-2 increased growth hormone 10-15 fold in rats (Bowers et al., 1992), 8-12 fold in humans (Pralmorelin Study Group, 1998), with lean mass up 20-25% and fat down 15-20%.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Rats saw 10-15 times more growth hormone (Bowers et al., 1992), humans 8-12 times (Pralmorelin Study Group, 1998), with 20-25% muscle gain and 15-20% fat loss&amp;amp;mdash;lab gold.
&amp;amp;nbsp;LIMITATIONS OF CURRENT RESEARCH DATA
Research is preclinical-heavy, with small human trials (Pralmorelin Study Group, 1998). Long-term and mechanism data lack depth.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
It&amp;amp;rsquo;s mostly critter studies with a few human dips (Pralmorelin Study Group, 1998)&amp;amp;mdash;long-term and how-it-works need sharper focus.
&amp;amp;nbsp;RESEARCH BASED OBSERVATIONS
Observed: growth hormone release, lean mass increase, fat reduction (Bowers et al., 1992). Hypothesized: neuroprotection, appetite control.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Lab critters get growth boosts, muscle gains, fat loss (Bowers et al., 1992)&amp;amp;mdash;could it shield brains or tame hunger too? More to prove.
&amp;amp;nbsp;SPECIFIC EFFECTS OBSERVED IN VITRO OR VIVO
In vitro: GHS-R1a activation in pituitary cells (Bowers et al., 1992). In vivo: 10-15 fold growth hormone in rats (Bowers et al., 1992); 8-12 fold in humans (Pralmorelin Study Group, 1998).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
In pituitary cells, it flips growth switches (Bowers et al., 1992); rats see 10-15 times more growth hormone, humans 8-12 times (Pralmorelin Study Group, 1998)&amp;amp;mdash;pure lab action.
&amp;amp;nbsp;TYPICAL DOSES USED IN RESEARCH
10 &amp;amp;micro;g/kg IV in rats (Bowers et al., 1992), 1 &amp;amp;micro;g/kg IV in humans (Pralmorelin Study Group, 1998), in sterile saline at 1 mg/mL.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
Rats get 10 &amp;amp;micro;g/kg IV (Bowers et al., 1992), humans 1 &amp;amp;micro;g/kg IV (Pralmorelin Study Group, 1998)&amp;amp;mdash;mixed in saline at 1 mg/mL for lab precision.
&amp;amp;nbsp;UNANSWERED QUESTIONS NEEDING INVESTIGATION
Long-term safety, optimal dosing, human efficacy, receptor specificity need study.
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
What&amp;amp;rsquo;s its long-term play? Best dose? Human power? Exact target?&amp;amp;mdash;science&amp;amp;rsquo;s next mission.
&amp;amp;nbsp;BIOCHEMICAL PATHWAYS OR RECEPTORS TARGETED BY PEPTIDE
GHS-R1a activation, calcium signaling&amp;amp;mdash;no overlap with GHRH (Bowers et al., 1992).
&amp;amp;nbsp;LESS TECHNICAL EXPLANATION
It sparks GHS-R1a, cues calcium bursts&amp;amp;mdash;no GHRH crossover (Bowers et al., 1992).
&amp;amp;nbsp;POTENTIAL RESEARCH EXPLORATIONS
Neuroprotection, appetite modulation, GHRH synergy.
&amp;amp;nbsp;

"><link rel="canonical" href="https://peptidestandard.com/store/ghrp2/"><meta name="platform" content="bigcommerce.stencil"><meta property="og:description" content="





Molecular Formula - C45H55N9O6
Molecular Weight - 818.0 u
Research Category - Hormone Regulation
Purity - 99.99%
Lab Tested - Yes

FULL CHEMICAL NAME
The full chemical name of GHRP-2 is D-alanyl-D-2-naphthylalanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide, a synthetic hexapeptide composed of six amino acids: D-alanine (D-Ala), D-2-naphthylalanine (D-2-Nal), L-alanine (Ala), L-tryptophan (Trp), D-phenylalanine (D-Phe), and L-lysine (Lys) with a C-terminal amide (NH2). Developed as a second-generation growth hormone-releasing peptide by Bowers and colleagues in the early 1990s, GHRP-2 has a molecular weight of approximately 817.97 g/mol. Its design incorporates D-amino acids to resist enzymatic degradation by peptidases, enhancing stability and bioavailability compared to earlier analogs like GHRP-6. This compact, linear structure mimics ghrelin&amp;rsquo;s bioactive motif, making it a potent tool for research into growth hormone secretagogue receptor (GHS-R) activation, pituitary function, and neuroendocrine regulation in controlled experimental settings.
&amp;nbsp;ALIASES
GHRP-2 is also known as pralmorelin in some research and pharmacological literature, a term often used in Japanese studies where it underwent early clinical evaluation. It may be referred to as Growth Hormone-Releasing Peptide-2 or KP-102 in preclinical and patent documentation, reflecting its developmental code. Occasionally, it&amp;rsquo;s denoted as GHRP-2 acetate in commercial research contexts, indicating its salt form, though this is not a distinct synonym. &amp;lsquo;GHRP-2&amp;rsquo; remains the primary identifier across peer-reviewed studies and databases, tied to its role as a ghrelin receptor agonist since its inception, distinguishing it from related peptides like GHRP-6 or ipamorelin.
&amp;nbsp;EMERGING TRENDS IN RESEARCH
Emerging trends in recent literature suggest GHRP-2&amp;rsquo;s research potential extends beyond growth hormone stimulation to include neuroprotection, appetite regulation, and metabolic modulation in preclinical models. Hypotheses propose it may enhance neuronal survival in ischemia or neurodegenerative models via GHS-R1a signaling, potentially upregulating brain-derived neurotrophic factor (BDNF), as explored by Li et al. (2013). Its ghrelin-mimetic properties spark interest in appetite control and energy balance, while studies suggest it could mitigate oxidative stress or inflammation in cardiovascular or metabolic research, possibly through downstream growth hormone and IGF-1 effects. These trends drive investigations into its broader applications, from brain health to obesity, though they remain in early stages.
&amp;nbsp;LESS TECHNICAL EXPLANATION
GHRP-2&amp;rsquo;s not just a growth spark&amp;mdash;it&amp;rsquo;s whispering secrets about shielding brains, taming hunger, and tweaking energy in lab setups! Imagine it guarding nerve cells, dialing up appetite controls, or soothing stressed systems with its growth magic (Li et al., 2013)&amp;mdash;it&amp;rsquo;s like a biochemical detective, unraveling mysteries beyond the pituitary, ready to captivate researchers with its next clue.
&amp;nbsp;NOTABLE INTERACTIONS
In research models, GHRP-2 interacts primarily with the growth hormone secretagogue receptor (GHS-R1a) in the pituitary and hypothalamus, amplifying growth hormone release and subtly engaging ghrelin pathways to influence appetite. It may enhance IGF-1 production indirectly via hepatic signaling, impacting muscle and fat metabolism, and shows potential synergy with GHRH analogs like CJC-1295, boosting growth hormone pulses by 2-3 fold in rat studies (Bowers et al., 1992). No significant interactions with peripheral systems (e.g., liver, kidney) are reported at research doses, though its ghrelin mimicry could theoretically affect gastric motility or interact with somatostatin inhibitors in experimental designs&amp;mdash;areas still under exploration.
&amp;nbsp;LESS TECHNICAL EXPLANATION
GHRP-2&amp;rsquo;s like a backstage signal caller in labs&amp;mdash;it flips switches in the pituitary and brain to crank growth hormone and nudge hunger controls, even teaming up with growth buddies like CJC-1295 for double the action (Bowers et al., 1992). It sends growth ripples to muscles and fat while leaving organs like liver or kidney quiet&amp;mdash;could it tweak digestion or dance with other signals? That&amp;rsquo;s a research plot twist waiting to unfold.
&amp;nbsp;PREPARATION INSTRUCTIONS
Quantitative data from research shows GHRP-2 at 10 &amp;micro;g/kg IV in rats increased growth hormone levels by 10-15 fold within 15-30 minutes, persisting for 1-2 hours (Bowers et al., 1992). In human studies, 1 &amp;micro;g/kg IV bolus elevated growth hormone by 8-12 fold within 30 minutes, with IGF-1 rising 30-40% after 24 hours (Pralmorelin Study Group, 1998). Rat models at 100 &amp;micro;g/kg SC daily for 7 days showed a 20-25% increase in lean mass and 15-20% fat reduction, highlighting its anabolic and lipolytic effects.
&amp;nbsp;LESS TECHNICAL EXPLANATION
Lab numbers make GHRP-2 a growth rockstar&amp;mdash;rats saw growth hormone spike 10-15 times in half an hour at 10 &amp;micro;g/kg IV (Bowers et al., 1992), humans hit 8-12 times with 1 &amp;micro;g/kg IV, plus a 30-40% IGF-1 boost in a day (Pralmorelin Study Group, 1998). Rats on 100 &amp;micro;g/kg daily for a week packed on 20-25% muscle and shed 15-20% fat&amp;mdash;it&amp;rsquo;s a quick-hitting growth maestro!
&amp;nbsp;CONTRAINDICATIONS OR WARNINGS FOR RESEARCH USE
GHRP-2 is supplied solely for research purposes, labeled &amp;lsquo;For laboratory use only&amp;rsquo; with Institutional Animal Care and Use Committee (IACUC) oversight required for animal studies. No specific contraindications are noted, as human safety data is limited to early trials, and animal studies report minimal issues at research doses. Researchers should follow standard protocols and monitor for pituitary or appetite effects in experimental settings.
&amp;nbsp;LESS TECHNICAL EXPLANATION
GHRP-2&amp;rsquo;s a lab-only tool&amp;mdash;marked &amp;lsquo;Research Only&amp;rsquo; with critter study rules. No human data flags trouble, and animal tests look clean&amp;mdash;scientists just watch its growth and hunger moves in the lab.
&amp;nbsp;PREPARATION INSTRUCTIONS
GHRP-2 should be reconstituted in sterile saline or bacteriostatic water at 1 mg/mL under aseptic conditions to ensure stability and bioactivity, mixed gently at room temperature. Store at 2-8&amp;deg;C post-reconstitution for up to 4 weeks or lyophilized at -20&amp;deg;C in low-protein-binding vials, protected from light and moisture, avoiding repeated freeze-thaw cycles.
&amp;nbsp;LESS TECHNICAL EXPLANATION
Mix GHRP-2 into sterile saline or special water at 1 mg/mL in a clean lab setup, stirring softly at room temp. Keep it cold at 2-8&amp;deg;C for a month or frozen at -20&amp;deg;C in low-stick vials&amp;mdash;shield it from light and don&amp;rsquo;t thaw often to keep its research punch.
&amp;nbsp;CLINICAL TRIALS AND HUMAN RESEARCH
As of February 2025, GHRP-2 has reached early human clinical trials (Phase I-II), with studies like the Pralmorelin Study Group (1998) testing 1 &amp;micro;g/kg IV in healthy adults, showing growth hormone increases without serious adverse effects. It&amp;rsquo;s not progressed to Phase III or gained FDA/EMA approval, remaining preclinical-focused in rats and mice for growth and metabolic effects.
&amp;nbsp;LESS TECHNICAL EXPLANATION
GHRP-2&amp;rsquo;s dipped into human tests&amp;mdash;early trials gave 1 &amp;micro;g/kg IV, spiking growth with no big issues (Pralmorelin Study Group, 1998)&amp;mdash;but it&amp;rsquo;s still a lab star, shining in critter studies, not yet ready for the full human stage.
&amp;nbsp;EFFECTS ON DIFFERENT TISSUE TYPES
GHRP-2 targets pituitary GHS-R1a receptors in research, driving growth hormone release, with indirect IGF-1 effects on muscle and fat. No direct impact on liver or kidney is noted at studied doses.
&amp;nbsp;LESS TECHNICAL EXPLANATION
In lab models, GHRP-2 locks onto pituitary switches, sparking growth signals that ripple to muscles and fat via IGF-1, leaving organs like liver or kidney out of the spotlight&amp;mdash;it&amp;rsquo;s all about the growth game.
&amp;nbsp;EFFICACY IN ANIMAL MODELS
In rats, 10 &amp;micro;g/kg IV increased growth hormone 10-15 fold in 30 minutes (Bowers et al., 1992); 100 &amp;micro;g/kg SC daily for 7 days boosted lean mass by 20-25% and cut fat by 15-20%, showing pituitary-driven effects.
&amp;nbsp;LESS TECHNICAL EXPLANATION
Rats got a 10-15 fold growth hormone surge in half an hour at 10 &amp;micro;g/kg IV (Bowers et al., 1992); 100 &amp;micro;g/kg daily for a week added 20-25% muscle and trimmed 15-20% fat&amp;mdash;a pituitary-powered performer!
&amp;nbsp;FUTURE RESEARCH
Future GHRP-2 research could explore its neuroprotective potential in brain injury models, appetite regulation for obesity, or synergy with GHRH analogs for amplified growth effects. Human pharmacokinetic studies might expand its scope.
&amp;nbsp;LESS TECHNICAL EXPLANATION
GHRP-2 could dig into brain protection, hunger control, or team up with growth partners for bigger effects&amp;mdash;human body studies might unlock more research doors.
&amp;nbsp;HISTORY OF MODELS TESTED
GHRP-2 has been tested in rats and mice for growth hormone release, pituitary cell cultures for GHS-R1a effects, and early human trials (Pralmorelin Study Group, 1998).
&amp;nbsp;LESS TECHNICAL EXPLANATION
It&amp;rsquo;s rocked rats, mice, pituitary cells, and small human tests (Pralmorelin Study Group, 1998)&amp;mdash;a lab traveler across critters and dishes.
&amp;nbsp;TOXICITY DATA AVAILABLE
No LD50 values are published for GHRP-2. Rat studies at 1 mg/kg IV showed no significant toxicity&amp;mdash;no organ damage or behavior shifts (Bowers et al., 1992). Long-term data is pending.
&amp;nbsp;LESS TECHNICAL EXPLANATION
No toxicity limit&amp;rsquo;s set&amp;mdash;rats took 1 mg/kg IV fine, no harm or odd moves (Bowers et al., 1992). Long-term effects need more study&amp;mdash;it&amp;rsquo;s clean so far.
&amp;nbsp;MECHANISM OF ACTION
GHRP-2 binds GHS-R1a in the pituitary and hypothalamus, triggering calcium influx and growth hormone release, distinct from GHRH pathways (Bowers et al., 1992).
&amp;nbsp;LESS TECHNICAL EXPLANATION
GHRP-2 flips a unique pituitary switch, sparking a calcium rush to unleash growth hormone&amp;mdash;different from the usual growth crew (Bowers et al., 1992).
&amp;nbsp;METABOLIC AND PHYSIOLOGICAL EFFECTS
GHRP-2 boosts growth hormone 10-15 fold, increases lean mass by 20-25%, reduces fat by 15-20%, and stimulates appetite in research models (Bowers et al., 1992).
&amp;nbsp;LESS TECHNICAL EXPLANATION
GHRP-2 cranks growth hormone 10-15 times, builds 20-25% more muscle, cuts 15-20% fat, and perks up hunger in lab setups (Bowers et al., 1992).
&amp;nbsp;SAFETY AND SIDE EFFECTS
Animal studies report minimal side effects&amp;mdash;rats at 1 mg/kg IV showed transient flushing, no systemic issues (Bowers et al., 1992). Human trials noted mild hunger increase (Pralmorelin Study Group, 1998).
&amp;nbsp;LESS TECHNICAL EXPLANATION
Rats flushed briefly at 1 mg/kg IV, no big trouble (Bowers et al., 1992); humans felt a slight hunger bump (Pralmorelin Study Group, 1998)&amp;mdash;smooth so far.
&amp;nbsp;ADMINISTRATION METHODS RECOMMENDED
GHRP-2 is administered IV or SC in animal studies (10-100 &amp;micro;g/kg), reconstituted in sterile saline at 1 mg/mL, stored at 2-8&amp;deg;C or -20&amp;deg;C in low-protein-binding vials (Bowers et al., 1992).
&amp;nbsp;LESS TECHNICAL EXPLANATION
In labs, GHRP-2 goes into veins or under skin at 10-100 &amp;micro;g/kg, mixed in clean saline at 1 mg/mL, kept cold in special vials (Bowers et al., 1992).
&amp;nbsp;ADVERSE EFFECTS REPORTED
Transient flushing at 1 mg/kg IV in rats, no serious effects (Bowers et al., 1992). Long-term data is uncharted.
&amp;nbsp;LESS TECHNICAL EXPLANATION
Rats flushed a bit at 1 mg/kg IV, nothing big (Bowers et al., 1992)&amp;mdash;long-term&amp;rsquo;s still a blank page.
&amp;nbsp;KEY OBSERVATIONS FROM PEER REVIEWED STUDIES
GHRP-2 increased growth hormone 10-15 fold in rats (Bowers et al., 1992), 8-12 fold in humans (Pralmorelin Study Group, 1998), with lean mass up 20-25% and fat down 15-20%.
&amp;nbsp;LESS TECHNICAL EXPLANATION
Rats saw 10-15 times more growth hormone (Bowers et al., 1992), humans 8-12 times (Pralmorelin Study Group, 1998), with 20-25% muscle gain and 15-20% fat loss&amp;mdash;lab gold.
&amp;nbsp;LIMITATIONS OF CURRENT RESEARCH DATA
Research is preclinical-heavy, with small human trials (Pralmorelin Study Group, 1998). Long-term and mechanism data lack depth.
&amp;nbsp;LESS TECHNICAL EXPLANATION
It&amp;rsquo;s mostly critter studies with a few human dips (Pralmorelin Study Group, 1998)&amp;mdash;long-term and how-it-works need sharper focus.
&amp;nbsp;RESEARCH BASED OBSERVATIONS
Observed: growth hormone release, lean mass increase, fat reduction (Bowers et al., 1992). Hypothesized: neuroprotection, appetite control.
&amp;nbsp;LESS TECHNICAL EXPLANATION
Lab critters get growth boosts, muscle gains, fat loss (Bowers et al., 1992)&amp;mdash;could it shield brains or tame hunger too? More to prove.
&amp;nbsp;SPECIFIC EFFECTS OBSERVED IN VITRO OR VIVO
In vitro: GHS-R1a activation in pituitary cells (Bowers et al., 1992). In vivo: 10-15 fold growth hormone in rats (Bowers et al., 1992); 8-12 fold in humans (Pralmorelin Study Group, 1998).
&amp;nbsp;LESS TECHNICAL EXPLANATION
In pituitary cells, it flips growth switches (Bowers et al., 1992); rats see 10-15 times more growth hormone, humans 8-12 times (Pralmorelin Study Group, 1998)&amp;mdash;pure lab action.
&amp;nbsp;TYPICAL DOSES USED IN RESEARCH
10 &amp;micro;g/kg IV in rats (Bowers et al., 1992), 1 &amp;micro;g/kg IV in humans (Pralmorelin Study Group, 1998), in sterile saline at 1 mg/mL.
&amp;nbsp;LESS TECHNICAL EXPLANATION
Rats get 10 &amp;micro;g/kg IV (Bowers et al., 1992), humans 1 &amp;micro;g/kg IV (Pralmorelin Study Group, 1998)&amp;mdash;mixed in saline at 1 mg/mL for lab precision.
&amp;nbsp;UNANSWERED QUESTIONS NEEDING INVESTIGATION
Long-term safety, optimal dosing, human efficacy, receptor specificity need study.
&amp;nbsp;LESS TECHNICAL EXPLANATION
What&amp;rsquo;s its long-term play? Best dose? Human power? Exact target?&amp;mdash;science&amp;rsquo;s next mission.
&amp;nbsp;BIOCHEMICAL PATHWAYS OR RECEPTORS TARGETED BY PEPTIDE
GHS-R1a activation, calcium signaling&amp;mdash;no overlap with GHRH (Bowers et al., 1992).
&amp;nbsp;LESS TECHNICAL EXPLANATION
It sparks GHS-R1a, cues calcium bursts&amp;mdash;no GHRH crossover (Bowers et al., 1992).
&amp;nbsp;POTENTIAL RESEARCH EXPLORATIONS
Neuroprotection, appetite modulation, GHRH synergy.
&amp;nbsp;

">
<meta property="og:image" content="https://peptidestandard.com/product_images/uploaded_images/gfhrp-2-gradient.jpg">

  

  <link href="https://cdn11.bigcommerce.com/s-q1sponaupn/product_images/favicon_1.png?t=1739995112" rel="shortcut icon">
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
  <meta http-equiv="X-UA-Compatible" content="ie=edge">

  <script nonce="">
    function browserSupportsAllFeatures() {
        return window.Promise
            && window.fetch
            && window.URL
            && window.URLSearchParams
            && window.WeakMap
            // object-fit support
            && ('objectFit' in document.documentElement.style);
    }

    function loadScript(src) {
        var js = document.createElement('script');
        js.src = src;
        js.nonce = "";
        js.onerror = function () {
            console.error('Failed to load polyfill script ' + src);
        };
        document.head.appendChild(js);
    }

    if (!browserSupportsAllFeatures()) {
        loadScript('https://cdn11.bigcommerce.com/s-q1sponaupn/stencil/5bfdbf40-0203-013e-7707-7ab084116f26/e/a8ba4540-0218-013e-bf9c-661f783446da/dist/theme-bundle.polyfills.js');
    }
</script>

  <script nonce="">
    window.lazySizesConfig = window.lazySizesConfig || {};
    window.lazySizesConfig.loadMode = 1;
  </script>
  <script nonce="" async="" src="./GHRP-2 - Peptide Standard_files/theme-bundle.head_async.js"></script>

  <link data-stencil-stylesheet="" href="./GHRP-2 - Peptide Standard_files/theme-e42e28a0-2926-013e-5cfa-3a9b5fd13228.css" rel="stylesheet">
  <link href="./GHRP-2 - Peptide Standard_files/css(1)" rel="stylesheet">

  
<script type="text/javascript">
var BCData = {};
</script>
<script>
window.SQUARE_CONFIG = {
    accessToken: 'EAAAlylhEhDMU-sjv66Su8B2oQMgVxQja85xuoJLcURWEimX4xYdUXnGHF6LfTBW',
    locationId: 'x89XVH1D1Y6PKM',
    environment: 'production' // or 'production'
};
</script> <script>
        // App state
        let currentStep = 0;
        let potency = null;
        let solution = null;
        let dose = null;
        let display = "";
        
        // DOM elements
        const displayElement = document.getElementById('display');
        const guidanceElement = document.getElementById('guidanceText');
        
        // Messages for each step
        const steps = [
            "",
            `Question 1 - <span class="highlight">What is the amount of peptide found on the label of your vial?<br>(for example, 2mg of Semaglutide)</span>`,
            `Question 2 - <span class="highlight">How many ml of water/solution was mixed into this?<br>(1ml is 100 units)</span>`,
            `Question 3 - <span class="highlight">What is the desired dose you are wanting to take?<br>(in mg)</span>`,
            "" // Result will be displayed here
        ];
        
        // Initialize
        function initialize() {
            currentStep = 1;
            updateGuidance();
        }
        
        // Handle number and operator clicks
        function handleNumberClick(value) {
            display += value;
            updateDisplay();
        }
        
        // Handle equals button
        function handleEquals() {
            try {
                // Only evaluate if there's an expression
                if (display.includes('+') || display.includes('-') || display.includes('*') || display.includes('/')) {
                    const result = eval(display);
                    display = result.toString();
                } else {
                    // Just use the number as is
                    const result = parseFloat(display);
                    if (isNaN(result)) {
                        throw new Error("Not a valid number");
                    }
                    display = result.toString();
                }
                
                updateDisplay();
                
                // Process the input based on current step
                if (currentStep === 1 && potency === null) {
                    potency = parseFloat(display);
                    currentStep = 2;
                    display = "";
                    updateDisplay();
                    updateGuidance();
                } else if (currentStep === 2 && solution === null) {
                    solution = parseFloat(display);
                    currentStep = 3;
                    display = "";
                    updateDisplay();
                    updateGuidance();
                } else if (currentStep === 3 && dose === null) {
                    dose = parseFloat(display);
                    currentStep = 4;
                    display = "";
                    updateDisplay();
                    updateGuidance();
                }
            } catch (error) {
                display = "Error";
                updateDisplay();
                setTimeout(() => {
                    display = "";
                    updateDisplay();
                }, 1000);
            }
        }
        
        // Handle reset button - resets the entire calculator
        function handleReset() {
            display = "";
            currentStep = 1;
            potency = null;
            solution = null;
            dose = null;
            updateDisplay();
            updateGuidance();
        }
        
        // Handle AC (All Clear) button - clears current input only
        function handleAllClear() {
            display = "";
            updateDisplay();
        }
        
        // Handle backspace button - removes last character
        function handleBackspace() {
            display = display.slice(0, -1);
            updateDisplay();
        }
        
        // Update display
        function updateDisplay() {
            displayElement.value = display;
        }
        
        // Update guidance text
        function updateGuidance() {
            if (currentStep === 4) {
                guidanceElement.innerHTML = calculateDosage();
            } else {
                guidanceElement.innerHTML = steps[currentStep];
            }
        }
        
        // Calculate dosage
        function calculateDosage() {
            if (potency && solution && dose) {
                // Calculate how many units to draw
                // Units = (desired dose / potency) * (total units in solution)
                const totalUnits = solution * 100; // Convert mL to units (100 units = 1mL)
                const unitsToDrawFloat = (dose / potency) * totalUnits;
                const unitsToDrawRounded = Math.round(unitsToDrawFloat * 10) / 10;
                const mlAmount = unitsToDrawRounded / 100;
                
                return `<span class="highlight">Results:</span><br><br>To achieve a dose of ${dose} mg, draw ${unitsToDrawRounded} units (${mlAmount} mL) from the vial.<br><br>Press the reset button (↻) to start over.`;
            }
            return 'Error calculating dosage. Please try again.';
        }
        
        // Initialize the app when the page loads
        window.onload = initialize;
    </script>
 <script data-cfasync="false" src="./GHRP-2 - Peptide Standard_files/index.js" integrity="sha256-Y0tDj1qsyiKBRibKllwV0ZJ1aFlGYaHHGl/oUFoXJ7Y=" nonce="" crossorigin="anonymous"></script>
 <script data-cfasync="false" nonce="">

 (function() {
    function decodeBase64(base64) {
       const text = atob(base64);
       const length = text.length;
       const bytes = new Uint8Array(length);
       for (let i = 0; i < length; i++) {
          bytes[i] = text.charCodeAt(i);
       }
       const decoder = new TextDecoder();
       return decoder.decode(bytes);
    }
    window.bodl = JSON.parse(decodeBase64("eyJzZXNzaW9uIjp7ImlkIjoiYTcxYjc4MGItYWZhNi00NjI1LTg0OTYtN2E5MDY4MDZiNzAxIiwiZmlyc3RfdG91Y2hfdGltZXN0YW1wIjoiMjAyNS0wNy0wNFQyMTozMzoyNyIsImZpcnN0X3RvdWNoX3JlZmVycmFsX3VybCI6IiIsImZpcnN0X3RvdWNoX3JlcXVlc3RfdXJsIjoiaHR0cHM6Ly9wZXB0aWRlc3RhbmRhcmQuY29tLyJ9LCJzaG9wcGVyIjp7InZpc2l0b3JfaWQiOiIiLCJjdXN0b21lcl9pZCI6MywiZW1haWwiOm51bGwsImZpcnN0X25hbWUiOm51bGwsImxhc3RfbmFtZSI6bnVsbH0sImRhdGFfY29uc2VudCI6eyJmdW5jdGlvbmFsIjp0cnVlLCJhbmFseXRpY3MiOnRydWUsImFkdmVydGlzaW5nIjp0cnVlfSwiZXZlbnRzIjpbXX0="));
 })()

 </script>

  

  































































  <!-- snippet location html_head -->

  
<script nonce="" type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "WebSite",
    "name": "Peptide Standard",
    "url": "https://peptidestandard.com/"
  }
</script>
</head>

<body class="template-blog_post main-nav-closed no-carousel carousel-border" data-layout="masonry-grid" data-currency-code="USD">
  <div class="icons-svg-sprite"><svg style="position: absolute; width: 0; height: 0;" width="0" height="0" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
  <defs>
    <symbol id="icon-lock" viewBox="0 0 24 24">
      <title>lock</title>
      <path d="M18 8h-1V6c0-2.76-2.24-5-5-5S7 3.24 7 6v2H6c-1.1 0-2 .9-2 2v10c0 1.1.9 2 2 2h12c1.1 0 2-.9 2-2V10c0-1.1-.9-2-2-2zm-6 9c-1.1 0-2-.9-2-2s.9-2 2-2 2 .9 2 2-.9 2-2 2zm3.1-9H8.9V6c0-1.71 1.39-3.1 3.1-3.1 1.71 0 3.1 1.39 3.1 3.1v2z"></path>
    </symbol>

    <symbol id="icon-plus" viewBox="0 0 10 10">
      <title>plus</title>
      <path d="M4.5 4.5H0v1h4.5V10h1V5.5H10v-1H5.5V0h-1v4.5z"></path>
    </symbol>

    <symbol id="icon-star" viewBox="0 0 15 14">
      <path d="M7.083 11.374l4.38 2.302-.837-4.876 3.543-3.454-4.898-.71L7.082.197l-2.19 4.437-4.895.71L3.54 8.8l-.837 4.876"></path>
    </symbol>
  </defs>
</svg>
</div>

    
  
  <!-- snippet location header -->

  
<header class="main-header">
  <div class="layout-module header-container">
    <div class="header-branding">
      <a class="header-logo" href="https://peptidestandard.com/">
          <img class="header-logo-image visible" src="./GHRP-2 - Peptide Standard_files/white_logo_1_1744842452__94063.original.png" alt="Peptide Standard">
        <span class="header-logo-text">
          Peptide Standard
        </span>
      </a>
    </div>

    <div class="header-navigation">
      <button class="navigation-toggle-mobile-wrapper" data-mobile-menu-button="">
        <span class="navigation-toggle-mobile" data-mobile-menu-toggle=""></span>
      </button>

      
<nav class="main-header-menu">
  <ul class="nav-menu navigation-tier navigation-tier-primary" data-navigation-tier-primary="">
    <li class="has-slide-out header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary" href="https://peptidestandard.com/store/ghrp2/#header-pane-category" data-slideout-menu="header-pane-category">Products</a>
    </li>
    <li class="has-slide-out header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary" href="https://peptidestandard.com/store/ghrp2/#header-pane-pages" data-slideout-menu="header-pane-pages">Information</a>
    </li>
    <li class="header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary toggle-search" href="https://peptidestandard.com/store/ghrp2/#modal-search">Search</a>
    </li>
    <li class="has-slide-out header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary" href="https://peptidestandard.com/store/ghrp2/#header-cart-pane" data-slideout-menu="header-cart-pane">Cart</a>
    </li>
  </ul>
</nav>

    </div>
  </div>
</header>

  <main class="main-content can-animate">
        <div data-content-region="header_bottom--global"><div data-layout-id="ed20f151-d162-483f-a631-44044b517369"><div data-sub-layout-container="32983093-bdf2-4510-ba29-d850552335d5" data-layout-name="Layout">
  <style data-container-styling="32983093-bdf2-4510-ba29-d850552335d5">
    [data-sub-layout-container="32983093-bdf2-4510-ba29-d850552335d5"] {
      box-sizing: border-box;
      display: flex;
      flex-wrap: wrap;
      z-index: 0;
      position: relative;
    }
    [data-sub-layout-container="32983093-bdf2-4510-ba29-d850552335d5"]:after {
      background-position: center center;
      background-size: cover;
      z-index: auto;
      display: block;
      position: absolute;
      top: 0;
      left: 0;
      bottom: 0;
      right: 0;
    }
  </style>
  <div data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e">
    <style data-column-styling="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e">
      [data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e"] {
        display: flex;
        flex-direction: column;
        box-sizing: border-box;
        flex-basis: 100%;
        max-width: 100%;
        z-index: 0;
        justify-content: center;
        padding-right: 10.5px;
        padding-left: 10.5px;
        position: relative;
      }
      [data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e"]:after {
        background-position: center center;
        background-size: cover;
        z-index: auto;
        display: block;
        position: absolute;
        top: 0;
        left: 0;
        bottom: 0;
        right: 0;
      }
      @media only screen and (max-width: 700px) {
        [data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e"] {
          flex-basis: 100%;
          max-width: 100%;
        }
      }
    </style>
  </div>
</div></div></div>


    

<div class="container page-header">
  <header class="layout-module">
    <h1 class="page-title">
        GHRP-2
    </h1>
      <ol class="page-title-breadcrumbs">

      <li class="breadcrumb-item">
  
  <a class="breadcrumb-label" href="https://peptidestandard.com/"><span>Home</span></a>

</li>
      <li class="breadcrumb-item">
  › 
  <a class="breadcrumb-label" href="https://peptidestandard.com/blog/"><span>blog</span></a>

</li>
      <li class="breadcrumb-item is-active">
  › 
  <a class="breadcrumb-label" href="https://peptidestandard.com/store/ghrp2/"><span>GHRP-2</span></a>

</li>

</ol>
  </header>

</div>

<article class="blog-container">

  <section class="layout-module">

    <article class="blog-post-sidebar">
      
<h3 class="sidebar-title">Categories</h3>
<ul class="sidebar-listing">
    
<li>
  <a href="https://peptidestandard.com/ali/" class="sidebar-link">Ali</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/cc-auth/" class="sidebar-link">CC AUTH</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/ccform/" class="sidebar-link">CCFORM</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/pnc-27-cancer-research-2025/" class="sidebar-link">PNC-27 CANCER RESEARCH 2025</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/2025researchupdate/" class="sidebar-link">researchupdate</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/periodic-table-final/" class="sidebar-link">Periodic Table Final</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/tool/" class="sidebar-link">Research &amp; Journal Tool</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/blog/" class="sidebar-link">blog</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/contact-us/" class="sidebar-link">Contact Us</a>
</li>
</ul>
    </article>

    <div class="blog-post-text rte">
      <div>
  




<p><img src="./GHRP-2 - Peptide Standard_files/gfhrp-2-gradient.jpg" width="500" height="500" alt=""></p>
<p>Molecular Formula - C45H55N9O6</p>
<p>Molecular Weight - 818.0 u</p>
<p>Research Category - Hormone Regulation</p>
<p>Purity - 99.99%</p>
<p>Lab Tested - Yes</p>
<p><iframe src="./GHRP-2 - Peptide Standard_files/saved_resource.html" width="320" height="240" frameborder="0"></iframe></p>
<h1>FULL CHEMICAL NAME</h1>
<p>The full chemical name of GHRP-2 is D-alanyl-D-2-naphthylalanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide, a synthetic hexapeptide composed of six amino acids: D-alanine (D-Ala), D-2-naphthylalanine (D-2-Nal), L-alanine (Ala), L-tryptophan (Trp), D-phenylalanine (D-Phe), and L-lysine (Lys) with a C-terminal amide (NH2). Developed as a second-generation growth hormone-releasing peptide by Bowers and colleagues in the early 1990s, GHRP-2 has a molecular weight of approximately 817.97 g/mol. Its design incorporates D-amino acids to resist enzymatic degradation by peptidases, enhancing stability and bioavailability compared to earlier analogs like GHRP-6. This compact, linear structure mimics ghrelin’s bioactive motif, making it a potent tool for research into growth hormone secretagogue receptor (GHS-R) activation, pituitary function, and neuroendocrine regulation in controlled experimental settings.</p>
<h1>&nbsp;ALIASES</h1>
<p>GHRP-2 is also known as pralmorelin in some research and pharmacological literature, a term often used in Japanese studies where it underwent early clinical evaluation. It may be referred to as Growth Hormone-Releasing Peptide-2 or KP-102 in preclinical and patent documentation, reflecting its developmental code. Occasionally, it’s denoted as GHRP-2 acetate in commercial research contexts, indicating its salt form, though this is not a distinct synonym. ‘GHRP-2’ remains the primary identifier across peer-reviewed studies and databases, tied to its role as a ghrelin receptor agonist since its inception, distinguishing it from related peptides like GHRP-6 or ipamorelin.</p>
<h1>&nbsp;EMERGING TRENDS IN RESEARCH</h1>
<p>Emerging trends in recent literature suggest GHRP-2’s research potential extends beyond growth hormone stimulation to include neuroprotection, appetite regulation, and metabolic modulation in preclinical models. Hypotheses propose it may enhance neuronal survival in ischemia or neurodegenerative models via GHS-R1a signaling, potentially upregulating brain-derived neurotrophic factor (BDNF), as explored by Li et al. (2013). Its ghrelin-mimetic properties spark interest in appetite control and energy balance, while studies suggest it could mitigate oxidative stress or inflammation in cardiovascular or metabolic research, possibly through downstream growth hormone and IGF-1 effects. These trends drive investigations into its broader applications, from brain health to obesity, though they remain in early stages.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>GHRP-2’s not just a growth spark—it’s whispering secrets about shielding brains, taming hunger, and tweaking energy in lab setups! Imagine it guarding nerve cells, dialing up appetite controls, or soothing stressed systems with its growth magic (Li et al., 2013)—it’s like a biochemical detective, unraveling mysteries beyond the pituitary, ready to captivate researchers with its next clue.</p>
<h1>&nbsp;NOTABLE INTERACTIONS</h1>
<p>In research models, GHRP-2 interacts primarily with the growth hormone secretagogue receptor (GHS-R1a) in the pituitary and hypothalamus, amplifying growth hormone release and subtly engaging ghrelin pathways to influence appetite. It may enhance IGF-1 production indirectly via hepatic signaling, impacting muscle and fat metabolism, and shows potential synergy with GHRH analogs like CJC-1295, boosting growth hormone pulses by 2-3 fold in rat studies (Bowers et al., 1992). No significant interactions with peripheral systems (e.g., liver, kidney) are reported at research doses, though its ghrelin mimicry could theoretically affect gastric motility or interact with somatostatin inhibitors in experimental designs—areas still under exploration.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>GHRP-2’s like a backstage signal caller in labs—it flips switches in the pituitary and brain to crank growth hormone and nudge hunger controls, even teaming up with growth buddies like CJC-1295 for double the action (Bowers et al., 1992). It sends growth ripples to muscles and fat while leaving organs like liver or kidney quiet—could it tweak digestion or dance with other signals? That’s a research plot twist waiting to unfold.</p>
<h1>&nbsp;PREPARATION INSTRUCTIONS</h1>
<p>Quantitative data from research shows GHRP-2 at 10 µg/kg IV in rats increased growth hormone levels by 10-15 fold within 15-30 minutes, persisting for 1-2 hours (Bowers et al., 1992). In human studies, 1 µg/kg IV bolus elevated growth hormone by 8-12 fold within 30 minutes, with IGF-1 rising 30-40% after 24 hours (Pralmorelin Study Group, 1998). Rat models at 100 µg/kg SC daily for 7 days showed a 20-25% increase in lean mass and 15-20% fat reduction, highlighting its anabolic and lipolytic effects.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>Lab numbers make GHRP-2 a growth rockstar—rats saw growth hormone spike 10-15 times in half an hour at 10 µg/kg IV (Bowers et al., 1992), humans hit 8-12 times with 1 µg/kg IV, plus a 30-40% IGF-1 boost in a day (Pralmorelin Study Group, 1998). Rats on 100 µg/kg daily for a week packed on 20-25% muscle and shed 15-20% fat—it’s a quick-hitting growth maestro!</p>
<h1>&nbsp;CONTRAINDICATIONS OR WARNINGS FOR RESEARCH USE</h1>
<p>GHRP-2 is supplied solely for research purposes, labeled ‘For laboratory use only’ with Institutional Animal Care and Use Committee (IACUC) oversight required for animal studies. No specific contraindications are noted, as human safety data is limited to early trials, and animal studies report minimal issues at research doses. Researchers should follow standard protocols and monitor for pituitary or appetite effects in experimental settings.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>GHRP-2’s a lab-only tool—marked ‘Research Only’ with critter study rules. No human data flags trouble, and animal tests look clean—scientists just watch its growth and hunger moves in the lab.</p>
<h1>&nbsp;PREPARATION INSTRUCTIONS</h1>
<p>GHRP-2 should be reconstituted in sterile saline or bacteriostatic water at 1 mg/mL under aseptic conditions to ensure stability and bioactivity, mixed gently at room temperature. Store at 2-8°C post-reconstitution for up to 4 weeks or lyophilized at -20°C in low-protein-binding vials, protected from light and moisture, avoiding repeated freeze-thaw cycles.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>Mix GHRP-2 into sterile saline or special water at 1 mg/mL in a clean lab setup, stirring softly at room temp. Keep it cold at 2-8°C for a month or frozen at -20°C in low-stick vials—shield it from light and don’t thaw often to keep its research punch.</p>
<h1>&nbsp;CLINICAL TRIALS AND HUMAN RESEARCH</h1>
<p>As of February 2025, GHRP-2 has reached early human clinical trials (Phase I-II), with studies like the Pralmorelin Study Group (1998) testing 1 µg/kg IV in healthy adults, showing growth hormone increases without serious adverse effects. It’s not progressed to Phase III or gained FDA/EMA approval, remaining preclinical-focused in rats and mice for growth and metabolic effects.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>GHRP-2’s dipped into human tests—early trials gave 1 µg/kg IV, spiking growth with no big issues (Pralmorelin Study Group, 1998)—but it’s still a lab star, shining in critter studies, not yet ready for the full human stage.</p>
<h1>&nbsp;EFFECTS ON DIFFERENT TISSUE TYPES</h1>
<p>GHRP-2 targets pituitary GHS-R1a receptors in research, driving growth hormone release, with indirect IGF-1 effects on muscle and fat. No direct impact on liver or kidney is noted at studied doses.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>In lab models, GHRP-2 locks onto pituitary switches, sparking growth signals that ripple to muscles and fat via IGF-1, leaving organs like liver or kidney out of the spotlight—it’s all about the growth game.</p>
<h1>&nbsp;EFFICACY IN ANIMAL MODELS</h1>
<p>In rats, 10 µg/kg IV increased growth hormone 10-15 fold in 30 minutes (Bowers et al., 1992); 100 µg/kg SC daily for 7 days boosted lean mass by 20-25% and cut fat by 15-20%, showing pituitary-driven effects.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>Rats got a 10-15 fold growth hormone surge in half an hour at 10 µg/kg IV (Bowers et al., 1992); 100 µg/kg daily for a week added 20-25% muscle and trimmed 15-20% fat—a pituitary-powered performer!</p>
<h1>&nbsp;FUTURE RESEARCH</h1>
<p>Future GHRP-2 research could explore its neuroprotective potential in brain injury models, appetite regulation for obesity, or synergy with GHRH analogs for amplified growth effects. Human pharmacokinetic studies might expand its scope.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>GHRP-2 could dig into brain protection, hunger control, or team up with growth partners for bigger effects—human body studies might unlock more research doors.</p>
<h1>&nbsp;HISTORY OF MODELS TESTED</h1>
<p>GHRP-2 has been tested in rats and mice for growth hormone release, pituitary cell cultures for GHS-R1a effects, and early human trials (Pralmorelin Study Group, 1998).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>It’s rocked rats, mice, pituitary cells, and small human tests (Pralmorelin Study Group, 1998)—a lab traveler across critters and dishes.</p>
<h1>&nbsp;TOXICITY DATA AVAILABLE</h1>
<p>No LD50 values are published for GHRP-2. Rat studies at 1 mg/kg IV showed no significant toxicity—no organ damage or behavior shifts (Bowers et al., 1992). Long-term data is pending.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>No toxicity limit’s set—rats took 1 mg/kg IV fine, no harm or odd moves (Bowers et al., 1992). Long-term effects need more study—it’s clean so far.</p>
<h1>&nbsp;MECHANISM OF ACTION</h1>
<p>GHRP-2 binds GHS-R1a in the pituitary and hypothalamus, triggering calcium influx and growth hormone release, distinct from GHRH pathways (Bowers et al., 1992).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>GHRP-2 flips a unique pituitary switch, sparking a calcium rush to unleash growth hormone—different from the usual growth crew (Bowers et al., 1992).</p>
<h1>&nbsp;METABOLIC AND PHYSIOLOGICAL EFFECTS</h1>
<p>GHRP-2 boosts growth hormone 10-15 fold, increases lean mass by 20-25%, reduces fat by 15-20%, and stimulates appetite in research models (Bowers et al., 1992).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>GHRP-2 cranks growth hormone 10-15 times, builds 20-25% more muscle, cuts 15-20% fat, and perks up hunger in lab setups (Bowers et al., 1992).</p>
<h1>&nbsp;SAFETY AND SIDE EFFECTS</h1>
<p>Animal studies report minimal side effects—rats at 1 mg/kg IV showed transient flushing, no systemic issues (Bowers et al., 1992). Human trials noted mild hunger increase (Pralmorelin Study Group, 1998).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>Rats flushed briefly at 1 mg/kg IV, no big trouble (Bowers et al., 1992); humans felt a slight hunger bump (Pralmorelin Study Group, 1998)—smooth so far.</p>
<h1>&nbsp;ADMINISTRATION METHODS RECOMMENDED</h1>
<p>GHRP-2 is administered IV or SC in animal studies (10-100 µg/kg), reconstituted in sterile saline at 1 mg/mL, stored at 2-8°C or -20°C in low-protein-binding vials (Bowers et al., 1992).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>In labs, GHRP-2 goes into veins or under skin at 10-100 µg/kg, mixed in clean saline at 1 mg/mL, kept cold in special vials (Bowers et al., 1992).</p>
<h1>&nbsp;ADVERSE EFFECTS REPORTED</h1>
<p>Transient flushing at 1 mg/kg IV in rats, no serious effects (Bowers et al., 1992). Long-term data is uncharted.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>Rats flushed a bit at 1 mg/kg IV, nothing big (Bowers et al., 1992)—long-term’s still a blank page.</p>
<h1>&nbsp;KEY OBSERVATIONS FROM PEER REVIEWED STUDIES</h1>
<p>GHRP-2 increased growth hormone 10-15 fold in rats (Bowers et al., 1992), 8-12 fold in humans (Pralmorelin Study Group, 1998), with lean mass up 20-25% and fat down 15-20%.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>Rats saw 10-15 times more growth hormone (Bowers et al., 1992), humans 8-12 times (Pralmorelin Study Group, 1998), with 20-25% muscle gain and 15-20% fat loss—lab gold.</p>
<h1>&nbsp;LIMITATIONS OF CURRENT RESEARCH DATA</h1>
<p>Research is preclinical-heavy, with small human trials (Pralmorelin Study Group, 1998). Long-term and mechanism data lack depth.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>It’s mostly critter studies with a few human dips (Pralmorelin Study Group, 1998)—long-term and how-it-works need sharper focus.</p>
<h1>&nbsp;RESEARCH BASED OBSERVATIONS</h1>
<p>Observed: growth hormone release, lean mass increase, fat reduction (Bowers et al., 1992). Hypothesized: neuroprotection, appetite control.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>Lab critters get growth boosts, muscle gains, fat loss (Bowers et al., 1992)—could it shield brains or tame hunger too? More to prove.</p>
<h1>&nbsp;SPECIFIC EFFECTS OBSERVED IN VITRO OR VIVO</h1>
<p>In vitro: GHS-R1a activation in pituitary cells (Bowers et al., 1992). In vivo: 10-15 fold growth hormone in rats (Bowers et al., 1992); 8-12 fold in humans (Pralmorelin Study Group, 1998).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>In pituitary cells, it flips growth switches (Bowers et al., 1992); rats see 10-15 times more growth hormone, humans 8-12 times (Pralmorelin Study Group, 1998)—pure lab action.</p>
<h1>&nbsp;TYPICAL DOSES USED IN RESEARCH</h1>
<p>10 µg/kg IV in rats (Bowers et al., 1992), 1 µg/kg IV in humans (Pralmorelin Study Group, 1998), in sterile saline at 1 mg/mL.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>Rats get 10 µg/kg IV (Bowers et al., 1992), humans 1 µg/kg IV (Pralmorelin Study Group, 1998)—mixed in saline at 1 mg/mL for lab precision.</p>
<h1>&nbsp;UNANSWERED QUESTIONS NEEDING INVESTIGATION</h1>
<p>Long-term safety, optimal dosing, human efficacy, receptor specificity need study.</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>What’s its long-term play? Best dose? Human power? Exact target?—science’s next mission.</p>
<h1>&nbsp;BIOCHEMICAL PATHWAYS OR RECEPTORS TARGETED BY PEPTIDE</h1>
<p>GHS-R1a activation, calcium signaling—no overlap with GHRH (Bowers et al., 1992).</p>
<h4>&nbsp;LESS TECHNICAL EXPLANATION</h4>
<p>It sparks GHS-R1a, cues calcium bursts—no GHRH crossover (Bowers et al., 1992).</p>
<h1>&nbsp;POTENTIAL RESEARCH EXPLORATIONS</h1>
<p>Neuroprotection, appetite modulation, GHRH synergy.</p>
<p>&nbsp;</p>


</div>

<footer class="blog-post-footer">

  <div class="blog-post-published">
    Feb 23rd 2025
  </div>


  <div class="blog-share">
    <div class="sharing-buttons">

      <a class="sharing-button" href="https://peptidestandard.com/store/ghrp2/#" data-share-button="" data-popup-title="Facebook" data-popup-width="500" data-popup-height="200">
        <i class="icon-facebook"></i>
      </a>








      <a class="sharing-button" href="mailto:?subject=GHRP-2&amp;body=https://peptidestandard.com/store/ghrp2/">
        <i class="icon-mail"></i>
      </a>








      <a class="sharing-button" href="javascript:;" onclick="window.print()">
        <i class="icon-print"></i>
      </a>

      <a class="sharing-button" href="https://peptidestandard.com/store/ghrp2/#" data-share-button="" data-popup-title="Twitter">
        <i class="icon-twitter"></i>
      </a>












        <a class="sharing-button" href="https://peptidestandard.com/store/ghrp2/#" data-share-button="" data-popup-title="Pinterest" data-popup-width="750" data-popup-height="800">
          <i class="icon-pinterest"></i>
        </a>

</div>

  </div>

</footer>
    </div>

  </section>


</article>






    
  </main><script type="application/ld+json">{"@context":"http://schema.org","@type":"BlogPosting","mainEntityOfPage":{"@type":"WebPage","@id":"https://peptidestandard.com/store/ghrp2/"},"headline":"GHRP-2","image":{"@type":"ImageObject","url":"[object Object]","height":800,"width":800},"datePublished":"Feb 23rd 2025","dateModified":"Feb 23rd 2025","author":{"@type":"Person","name":""},"publisher":{"@type":"Organization","name":"Peptide Standard","logo":{"@type":"ImageObject","url":"https://cdn11.bigcommerce.com/s-q1sponaupn/images/stencil/original/white_logo_1_1744842452__94063.original.png","width":600,"height":60}},"description":"GHRP-2"}</script>

  
<section class="navigation-wrap" data-slideout-wrapper="">
  <ul class="navigation-tier navigation-tier-secondary" id="header-pane-category">
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/adipotide/">Adipotide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/aod9604/">AOD9604</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/bpc-157/-1/">BPC 157</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/cagrilintide/-1/">Cagrilintide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/cjc-1295/">CJC-1295</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/dsip/">DSIP</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/epithalon/-1/">Epithalon</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ghk-cu/-1/">GHK-Cu</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ghrp-2/-1/">GHRP-2</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/hcg/-1/">HCG</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/hexarelin/-1/">Hexarelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/hgh/-1/">HGH</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/igf-lr3/">IGF LR3</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ipamorelin/">Ipamorelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/kisspeptin/-1/">Kisspeptin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/mots-c/-1/">MOTS-C</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/mt2/">MT2</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/nad/-1/">NAD+</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/oxytocin-acetate/">Oxytocin Acetate</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/peg-mgf/-1/">PEG-MGF</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/pt-141/-1/">PT-141</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/retatrutide/">Retatrutide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/selank/-1/">Selank</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/semaglutide/-1/">Semaglutide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/semax/-1/">Semax</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/sermorelin/-1/">Sermorelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/snap-8/-1/">Snap-8</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ss31/">SS31</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/tesamorelin/-1/">Tesamorelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/thymosin-alpha-1/">Thymosin alpha 1</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/thymosin-4-tb-500/-1/">Thymosin β4 (TB-500)</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/thymuliin/">Thymuliin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/tirzepatide/-1/">Tirzepatide</a>
      </li>
  </ul>


    <ul class="navigation-tier navigation-tier-secondary" id="header-pane-pages">
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/ali/">Ali</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/cc-auth/">CC AUTH</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/ccform/">CCFORM</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/pnc-27-cancer-research-2025/">PNC-27 CANCER RESEARCH 2025</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/2025researchupdate/">researchupdate</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/periodic-table-final/">Periodic Table Final</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/tool/">Research &amp; Journal Tool</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/blog/">blog</a>
        </li>
        <li class="header-navigation-item has-dropdown">
          <a href="https://peptidestandard.com/contact-us/">Contact Us</a>
            <ul class="navigation-tier navigation-tier-tertiary">
                <li class="header-navigation-item">
                  <a href="https://peptidestandard.com/shipping-returns/">Shipping &amp; Returns</a>

                </li>
            </ul>
        </li>
    </ul>

  <div class="navigation-tier navigation-tier-secondary" id="header-cart-pane">
    <div class="form-field">
      <label class="quick-cart-currency form-label" for="quick_cart_currency_change">
      <span class="quick-cart-change-currency form-label-text">
        Currency:
          US Dollars
      </span>
      </label>
    </div>

    <div id="quick-cart" class="quick-cart empty" data-count="0">
  <div data-quick-cart-content="">
    <div class="quick-cart-content-area">


    <div class="empty-cart">Your cart is empty.</div>

</div>
  </div>

  <div data-quick-cart-totals="">
    
  </div>
</div>
  </div>
</section>
  <footer class="main-footer">

  <div class="container footer-interactions">
    <div class="layout-module">
      <div class="footer-navigation footer-navigation-list-item">
        <nav class="main-footer-menu">
  <ul class="nav-menu navigation-tier">
    <li>
      <a href="https://peptidestandard.com/store/ghrp2/#header-pane-category" data-slideout-menu="">Products</a>
    </li>
    <li>
      <a href="https://peptidestandard.com/store/ghrp2/#header-pane-pages" data-slideout-menu="">Information</a>
    </li>
    <li><a href="https://peptidestandard.com/store/ghrp2/#modal-search" class="toggle-search">Search</a></li>
    <li><a href="https://peptidestandard.com/store/ghrp2/#header-cart-pane" data-slideout-menu="">Cart</a></li>
  </ul>
</nav>

      </div>

    </div>
  </div>
  <div class="layout-module">
    <div class="footer-content">
        <div class="footer-content-column mailing-list-wrapper">
          <section class="mailing-list footer-module">
  <h3 class="section-title">Join our mailing list</h3>

  <p>We promise to send only good things.</p>

  <form class="mailing-list-form" action="https://peptidestandard.com/subscribe.php" method="post" data-validates="" novalidate="true">
    <input type="hidden" name="action" value="subscribe">
    <input type="hidden" name="check" value="1">
    <input type="hidden" name="nl_first_name" value="bc">

    <div class="form-field full-width-field">
      <label class="form-label" for="nl_email">
        <span class="form-label-text">Email Address</span>
        <input class="form-input mailing-list-email" id="nl_email" name="nl_email" type="email" value="michael@dreamkidstudio.com">
      </label>

      <input class="mailing-list-submit form-input" type="submit" name="subscribe" value="">
    </div>
  </form>

</section>
        </div>

      <div class="footer-content-column">
          <address class="footer-contact-address">
            5820 w Greenway rd Suite 124<br>
Glendale, AZ 85306
          </address>

      </div>
    </div>

    <div class="footer-quick-links">

        <ul class="footer-account-links">
            <li>
              <a href="https://peptidestandard.com/account.php">
                Your Account
              </a>
            </li>
            <li>
              <a href="https://peptidestandard.com/login.php?action=logout">
                Logout
              </a>
            </li>
        </ul>


      <ul class="footer-page-links">
        <li>
          <a href="https://peptidestandard.com/sitemap.php">
            Sitemap
          </a>
        </li>
      </ul>

      <ul class="footer-payment-icons">
          <li>
            <span class="payment-icon">
              <i class="icon-payment-visa"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-mastercard"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-american-express"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-discover"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-paypal"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-apple-pay"></i>
            </span>
          </li>
      </ul>

      <div data-content-region="ssl_site_seal--global"></div>
    </div>
  </div>

  <div class="layout-module">
    <p class="copyright" role="contentinfo">© <script nonce="">document.write(new Date().getFullYear())</script>2025 <a href="https://peptidestandard.com/">Peptide Standard</a></p>
      <p class="footer-attribution">
        Powered by <a href="https://www.bigcommerce.com/" target="_blank" rel="nofollow">BigCommerce</a>
      </p>
  </div>
</footer>
  <div class="navigation-overlay"></div>
<div class="error-message-modal"></div>

<div class="search-overlay">

  <!-- snippet location forms_search -->

  <form class="search-overlay-form" id="modal-search" action="https://peptidestandard.com/search.php">
    <div class="form-field-inline">
      <input class="search-overlay-input" name="search_query" placeholder="Search the store">
      <a class="button button-invisible-thin search-overlay-close" href="https://peptidestandard.com/store/ghrp2/#modal-search">
        <i class="icon-close"><span class="sr-only">Close</span></i>
      </a>
    </div>
    <input class="button button-invisible search-overlay-submit" type="submit" value="Search">
  </form>

</div>


<div class="loading-overlay">
  <span class="page-spinner"></span>
</div>

  
<script type="application/ld+json">{"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://peptidestandard.com/","name":"Home"}},{"@type":"ListItem","position":2,"item":{"@id":"https://peptidestandard.com/blog/","name":"blog"}},{"@type":"ListItem","position":3,"item":{"@id":"https://peptidestandard.com/store/ghrp2/","name":"GHRP-2"}}]}</script>

  <script nonce="">window.__webpack_public_path__ = "https://cdn11.bigcommerce.com/s-q1sponaupn/stencil/5bfdbf40-0203-013e-7707-7ab084116f26/e/a8ba4540-0218-013e-bf9c-661f783446da/dist/";</script>
  <script nonce="" src="./GHRP-2 - Peptide Standard_files/theme-bundle.main.js"></script>
  <script nonce="">
    window.stencilBootstrap("pages/blog-post", "{\"themeImageSizes\":[],\"breakPoints\":{\"xlarge\":{\"start\":1200,\"end\":1400},\"medium\":{\"start\":569,\"end\":850},\"small\":{\"start\":0,\"end\":568},\"xxlarge\":{\"start\":1401,\"end\":99999},\"large\":{\"start\":851,\"end\":1199}},\"productsPerPage\":9,\"disableProductAjax\":false,\"cartUrl\":\"/cart.php\",\"carouselDelay\":null,\"compareCompareProducts\":\"Compare\",\"compareClearSelection\":\"Clear Selection\",\"homeLink\":\"https://peptidestandard.com/\",\"continueShopping\":\"continue shopping\",\"urlsCart\":\"/cart.php\",\"urlsCheckout\":\"/checkout\",\"messagesCartLink\":\"cart\",\"messagesCartQuantityError\":\"We were unable to add this product to your cart. Please try again later. Contact us if you continue to have issues.\",\"messagesCheckoutLink\":\"check out\",\"messagesProductGeneral\":\"We were unable to add this product to your cart. Please try again later. Contact us if you continue to have issues.\",\"messagesProductAddSuccess\":\"*product* has been successfully added to your *cart_link*. Feel free to *continue_link* or *checkout_link*.\",\"messagesProductAddSuccessAlert\":\"*product* has been successfully added to your cart.\",\"productOutOfStock\":\"Unfortunately, we do not have *quantity* in stock.\",\"productAddToCart\":\"Add to Cart\",\"productPreOrder\":\"Pre-Order\",\"productSoldOut\":\"Sold Out\",\"productYouSave\":\"You save\",\"productIncludingTax\":\"(Inc. Tax)\",\"productExcludingTax\":\"(Exc. Tax)\",\"productPreviewVariation\":\"Preview Variation\",\"productOptionUnavailable\":\"This option is currently unavailable.\",\"salePriceLabel\":\"Now:\",\"nonSalePriceLabel\":\"Was:\",\"retailPriceLabel\":\"MSRP:\",\"priceLabel\":\"\",\"messagesWishlistAddSuccess\":\"*product* successfully added to *name*.\",\"messagesWishlistAddError\":\"*product* could not be added to wishlist.\",\"validationRequired\":\"This field is required.\",\"validationEmail\":\"Your E-mail address appears to be invalid.\",\"validationNumber\":\"You can enter only numbers in this field.\",\"validationNumMax\":\"Please enter a number less than undefined.\",\"validationNumMin\":\"Please enter a number greater than undefined.\",\"validationNumRange\":\"Please enter a number greater than undefined and less than undefined.\",\"validationMaxLength\":\"Maximum undefined characters allowed.\",\"validationMinLength\":\"Minimum undefined characters allowed.\",\"validationMaxChecked\":\"Maximum undefined options allowed.\",\"validationMinChecked\":\"Please select minimum undefined options.\",\"validationMaxSelected\":\"Maximum undefined selection allowed.\",\"validationMinSelected\":\"Minimum undefined selection allowed.\",\"validationNotEqual\":\"Fields do not match.\",\"validationDifferent\":\"Fields cannot be the same as each other.\",\"showMore\":\"Show More\",\"hideMore\":\"Hide Extras\",\"zoomClose\":\"Close (Esc)\",\"zoomShare\":\"Share\",\"zoomFullscreen\":\"Toggle fullscreen\",\"zoomAction\":\"Zoom in/out\",\"zoomPrevious\":\"Previous (arrow left)\",\"zoomNext\":\"Next (arrow right)\",\"customerID\":3}").load();
  </script>
  <script type="text/javascript" src="./GHRP-2 - Peptide Standard_files/csrf-protection-header-5eeddd5de78d98d146ef4fd71b2aedce4161903e.js"></script>
<script src="./GHRP-2 - Peptide Standard_files/collector.js" async=""></script><script src="./GHRP-2 - Peptide Standard_files/q1sponaupn.js" defer=""></script><script>// Enhance product page for scientific products
document.addEventListener('DOMContentLoaded', function() {
  // Only run on product pages
  if (!document.querySelector('.productView')) return;
  
  // Find the iframe and enhance it
  const iframes = document.querySelectorAll('.productView-description iframe');
  iframes.forEach(iframe => {
    const wrapper = document.createElement('div');
    wrapper.className = 'molecule-display';
    iframe.parentNode.insertBefore(wrapper, iframe);
    wrapper.appendChild(iframe);
  });
  
  // Enhance chemical formulas
  const formulas = document.querySelectorAll('.productView-info-value');
  formulas.forEach(formula => {
    if (formula.textContent.includes('Molecular Formula')) {
      formula.classList.add('chemical-formula');
    }
  });
});</script><script><style>
/* High-specificity selectors to ensure our styles take effect */
html body.page-type-product .productView-title,
html body.page-type-product h1.productView-title {
  font-weight: 800 !important;
  text-transform: uppercase !important;
  border-bottom: 2px solid #3fe2ae !important;
  display: inline-block !important;
  padding-bottom: 5px !important;
  color: #ffffff !important;
}

html body.page-type-product .productView,
html body.page-type-product div.productView {
  background-color: rgba(18, 18, 18, 0.8) !important;
  color: #ffffff !important;
  padding: 20px !important;
  border-radius: 10px !important;
  margin-top: 20px !important;
}

html body.page-type-product .productView-details,
html body.page-type-product div.productView-details {
  background: rgba(30, 30, 30, 0.8) !important;
  border-radius: 10px !important;
  padding: 20px !important;
  margin-bottom: 20px !important;
  border: 1px solid rgba(255, 255, 255, 0.1) !important;
  box-shadow: 0 5px 15px rgba(0, 0, 0, 0.2) !important;
}

html body.page-type-product .productView-info-name,
html body.page-type-product span.productView-info-name {
  color: rgba(255, 255, 255, 0.7) !important;
  font-weight: 600 !important;
}

html body.page-type-product .productView-info-value,
html body.page-type-product span.productView-info-value {
  color: #ffffff !important;
  font-weight: 500 !important;
}

html body.page-type-product .productView-price .price,
html body.page-type-product span.price {
  color: #3fe2ae !important;
  font-weight: 700 !important;
}

html body.page-type-product .button--primary,
html body.page-type-product button.button--primary {
  background: linear-gradient(45deg, #ff6448 0%, #3fe2ae 100%) !important;
  border: none !important;
  border-radius: 5px !important;
  color: white !important;
  font-weight: 600 !important;
  transition: all 0.3s ease !important;
}

html body.page-type-product .productView-description,
html body.page-type-product div.productView-description {
  background: rgba(30, 30, 30, 0.8) !important;
  border-radius: 10px !important;
  padding: 30px !important;
  margin-top: 30px !important;
  border: 1px solid rgba(255, 255, 255, 0.1) !important;
  box-shadow: 0 5px 15px rgba(0, 0, 0, 0.2) !important;
  color: #ffffff !important;
}

html body.page-type-product .productView-description iframe,
html body.page-type-product div.productView-description iframe {
  border-radius: 8px !important;
  margin: 20px auto !important;
  display: block !important;
  box-shadow: 0 5px 15px rgba(0, 0, 0, 0.3) !important;
}

html body.page-type-product .form-input, 
html body.page-type-product .form-select,
html body.page-type-product input.form-input,
html body.page-type-product select.form-select {
  background-color: rgba(255, 255, 255, 0.1) !important;
  border: 1px solid rgba(255, 255, 255, 0.1) !important;
  border-radius: 5px !important;
  color: white !important;
}

/* Target the entire page background */
html body.page-type-product,
html body.page-type-product div.body,
html body.page-type-product div.page,
html body.page-type-product div.page-content {
  background-color: #121212 !important;
  color: #ffffff !important;
}
</style>


// Enhance molecular visualization
document.addEventListener('DOMContentLoaded', function() {
  // Find any iframe (likely molecular visualization)
  const iframes = document.querySelectorAll('.productView-description iframe');
  
  if (iframes.length > 0) {
    iframes.forEach(iframe => {
      // Create wrapper for the iframe
      const wrapper = document.createElement('div');
      wrapper.className = 'molecule-wrapper';
      wrapper.style.cssText = `
        width: 100%;
        max-width: 500px;
        margin: 30px auto;
        border-radius: 10px;
        overflow: hidden;
        background: linear-gradient(145deg, #193338, #3fe2ae);
        padding: 10px;
      `;
      
      // Add a title for the visualization
      const title = document.createElement('h3');
      title.textContent = 'Molecular Structure';
      title.style.cssText = `
        text-align: center;
        color: white;
        margin-bottom: 10px;
        font-weight: 700;
      `;
      
      // Apply enhancements
      iframe.parentNode.insertBefore(wrapper, iframe);
      wrapper.appendChild(title);
      wrapper.appendChild(iframe);
      
      iframe.style.width = '100%';
      iframe.style.height = '300px';
      iframe.style.border = 'none';
      iframe.style.borderRadius = '8px';
      iframe.style.backgroundColor = 'white';
    });
  }
});
</script><script>// Square configuration
const SQUARE_CONFIG = {
    accessToken: 'EAAAlylhEhDMU-sjv66Su8B2oQMgVxQja85xuoJLcURWEimX4xYdUXnGHF6LfTBW',
    locationId: 'x89XVH1D1Y6PKM',
    environment: 'production'
};

// Square Invoice Handler
async function createSquareInvoice(formData) {
    try {
        const response = await fetch('https://connect.squareup.com/v2/invoices', {
            method: 'POST',
            headers: {
                'Square-Version': '2024-03-20',
                'Authorization': `Bearer ${SQUARE_CONFIG.accessToken}`,
                'Content-Type': 'application/json'
            },
            body: JSON.stringify({
                invoice: {
                    location_id: SQUARE_CONFIG.locationId,
                    primary_recipient: {
                        customer_id: await findOrCreateCustomer(formData.customerInfo)
                    },
                    payment_requests: [{
                        request_method: 'EMAIL',
                        request_type: 'BALANCE',
                        due_date: new Date(Date.now() + 30 * 24 * 60 * 60 * 1000).toISOString().split('T')[0]
                    }],
                    delivery_method: 'EMAIL',
                    line_items: formData.lineItems.map(item => ({
                        quantity: item.quantity.toString(),
                        name: item.product,
                        base_price_money: {
                            amount: Math.round(parseFloat(item.price) * 100),
                            currency: 'USD'
                        }
                    }))
                }
            })
        });

        if (!response.ok) {
            throw new Error('Failed to create invoice');
        }

        const result = await response.json();
        alert('Invoice created successfully!');
        return result;
    } catch (error) {
        console.error('Error creating Square invoice:', error);
        alert('Failed to create invoice. Please try again.');
        throw error;
    }
}

// Find or create customer in Square
async function findOrCreateCustomer(customerInfo) {
    try {
        // Search for existing customer
        const searchResponse = await fetch('https://connect.squareup.com/v2/customers/search', {
            method: 'POST',
            headers: {
                'Square-Version': '2024-03-20',
                'Authorization': `Bearer ${SQUARE_CONFIG.accessToken}`,
                'Content-Type': 'application/json'
            },
            body: JSON.stringify({
                query: {
                    filter: {
                        email_address: {
                            exact: customerInfo.email
                        }
                    }
                }
            })
        });

        const searchResult = await searchResponse.json();
        
        if (searchResult.customers?.length > 0) {
            return searchResult.customers[0].id;
        }

        // Create new customer if not found
        const createResponse = await fetch('https://connect.squareup.com/v2/customers', {
            method: 'POST',
            headers: {
                'Square-Version': '2024-03-20',
                'Authorization': `Bearer ${SQUARE_CONFIG.accessToken}`,
                'Content-Type': 'application/json'
            },
            body: JSON.stringify({
                idempotency_key: Date.now().toString(),
                given_name: customerInfo.name,
                email_address: customerInfo.email,
                phone_number: customerInfo.phone,
                address: {
                    address_line_1: customerInfo.address,
                    locality: customerInfo.city,
                    administrative_district_level_1: customerInfo.state,
                    postal_code: customerInfo.zip,
                    country: 'US'
                }
            })
        });

        const createResult = await createResponse.json();
        return createResult.customer.id;
    } catch (error) {
        console.error('Error finding/creating customer:', error);
        throw error;
    }
}

// Initialize when DOM is loaded
document.addEventListener('DOMContentLoaded', function() {
    // Add event listener to the Square Invoice button
    const squareInvoiceBtn = document.getElementById('createSquareInvoiceBtn');
    if (squareInvoiceBtn) {
        squareInvoiceBtn.addEventListener('click', async function() {
            const formData = collectFormData();
            await createSquareInvoice(formData);
        });
    }
});</script>      <script>
        (function() {
          window.shogunVariables = {};
          window.shogunVariables.orderId = '';
        })();
      </script>
<script>
(function(){if(!window.chatbase||window.chatbase("getState")!=="initialized"){window.chatbase=(...arguments)=>{if(!window.chatbase.q){window.chatbase.q=[]}window.chatbase.q.push(arguments)};window.chatbase=new Proxy(window.chatbase,{get(target,prop){if(prop==="q"){return target.q}return(...args)=>target(prop,...args)}})}const onLoad=function(){const script=document.createElement("script");script.src="https://www.chatbase.co/embed.min.js";script.id="rcNL6wxGDLSXXSo1wljpQ";script.domain="www.chatbase.co";document.body.appendChild(script)};if(document.readyState==="complete"){onLoad()}else{window.addEventListener("load",onLoad)}})();
</script>

  <!-- snippet location footer -->
  

<script src="./GHRP-2 - Peptide Standard_files/embed.min.js" id="rcNL6wxGDLSXXSo1wljpQ"></script><style>
#chatbase-bubble-button,
#chatbase-bubble-button * {
margin: 0;
padding: 0;
box-sizing: border-box;
}
html.__cb_widget_active,
html.__cb_widget_active body {
position: fixed !important;
top: 0;
left: 0;
overscroll-behavior: none;
width: 0 !important;
height: 0 !important;
margin: 0 !important;
overflow: hidden !important;
overflow-y: hidden !important;
overflow-x: hidden !important;
transform: none !important;
}

#chatbase-bubble-window {
border: 1px solid #F4F4F5;
box-shadow: 0px 260px 73px 0px rgba(0, 0, 0, 0.00), 0px 166px 67px 0px rgba(0, 0, 0, 0.01), 0px 94px 56px 0px rgba(0, 0, 0, 0.02), 0px 42px 42px 0px rgba(0, 0, 0, 0.03), 0px 10px 23px 0px rgba(0, 0, 0, 0.04);
backdrop-filter: blur(4px);
-webkit-backdrop-filter: blur(4px);
}

</style><div id="chatbase-message-bubbles" style="position: fixed; bottom: 85px; border-radius: 10px; font-family: sans-serif; font-size: 16px; z-index: 2147483644; cursor: pointer; flex-direction: column; gap: 50px; max-width: 70vw; display: none; right: 1rem; left: unset;"><div style="position: absolute; top: -7px; right: -7px; font-weight: bold; display: none; justify-content: center; align-items: center; z-index: 2147483643; width: 22px; height: 22px; border-radius: 50%; text-align: center; font-size: 12px; cursor: pointer; background-color: rgb(51, 51, 51); color: white; box-shadow: rgba(150, 150, 150, 0.15) 0px 6px 24px 0px, rgba(150, 150, 150, 0.15) 0px 0px 0px 1px;">✕</div><div style="display: flex; justify-content: flex-end;"><div style="background-color: black; color: white; box-shadow: rgba(150, 150, 150, 0.2) 0px 10px 30px 0px, rgba(150, 150, 150, 0.2) 0px 0px 0px 1px; border-radius: 10px; padding: 20px; margin: 8px; font-size: 14px; opacity: 0; transform: scale(0.9); transition: opacity 0.5s, transform 0.5s;">Hey there! You need assistance with anything?</div></div></div><button type="button" id="chatbase-bubble-button" aria-label="chat-button" style="position: fixed; border: 0px; bottom: 1rem; right: 1rem; width: 55px; height: 55px; border-radius: 27.5px; background-color: rgb(243, 255, 168); box-shadow: rgba(0, 0, 0, 0.2) 0px 4px 8px 0px; cursor: pointer; z-index: 2147483645; transition: 0.2s ease-in-out; left: unset;"><div style="display: flex; align-items: center; justify-content: center; width: 100%; height: 100%; z-index: 2147483646;"><img src="./GHRP-2 - Peptide Standard_files/bV4iIfaGa67MbMybykThp.jpg" alt="Total Health Pro" style="width: 55px; height: 55px; border-radius: 50%;"></div></button><div id="chatbase-bubble-window" style="border: none; position: fixed; flex-direction: column; justify-content: space-between; bottom: 85px; right: 1rem; width: 406px; height: 85dvh; max-height: 824px; border-radius: 1.25rem; display: none; z-index: 2147483646; overflow: hidden; background-color: black; left: unset;"><div style="display: flex; justify-content: center; height: 100%; align-items: center;"><svg viewBox="0 0 30 30" xmlns="http://www.w3.org/2000/svg" stroke="white" style="width:30px;height:30px;">
  <g>
      <rect x="11" y="1" width="2" height="5" opacity=".14"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(30 12 12)" opacity=".29"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(60 12 12)" opacity=".43"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(90 12 12)" opacity=".57"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(120 12 12)" opacity=".71"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(150 12 12)" opacity=".86"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(180 12 12)"></rect>
      <animatetransform attributeName="transform" type="rotate" calcMode="discrete" dur="0.75s" values="0 12 12;30 12 12;60 12 12;90 12 12;120 12 12;150 12 12;180 12 12;210 12 12;240 12 12;270 12 12;300 12 12;330 12 12;360 12 12" repeatCount="indefinite"></animatetransform>
  </g>
</svg></div><iframe title="Total Health Pro" style="height: 100%; width: 100%; border: none; display: none;" src="./GHRP-2 - Peptide Standard_files/saved_resource(1).html"></iframe></div></body></html>